According to a source familiar with the matter at hand, GoodRx Holdings Inc has priced its initial public offering (IPO) at $33 per share, above its target range.
The U.S.-based online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.
GoodRx did not immediately respond to requests for comments.
Categories: Creativity, Entrepreneurship, HR & Organization, Strategy
manageria.biz 
Leave a comment